Total Payments
$6,978
2024 Payments
$1,119
Companies
59
Transactions
319
Medicare Patients
4,141
Medicare Billing
$881,276
Payment Breakdown by Category
Food & Beverage$5,292 (75.8%)
Other$1,198 (17.2%)
Education$488.35 (7.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,292 | 287 | 75.8% |
| Long term medical supply or device loan | $1,198 | 13 | 17.2% |
| Education | $488.35 | 19 | 7.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,522 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $467.55 | 20 | $0 (2023) |
| Amgen Inc. | $431.82 | 16 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $348.74 | 15 | $0 (2024) |
| PFIZER INC. | $341.09 | 32 | $0 (2024) |
| Seagen Inc. | $316.18 | 12 | $0 (2023) |
| Genentech USA, Inc. | $280.48 | 22 | $0 (2019) |
| Celgene Corporation | $215.96 | 11 | $0 (2023) |
| GENZYME CORPORATION | $207.33 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $205.36 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,119 | 33 | Novartis Pharmaceuticals Corporation ($539.33) |
| 2023 | $1,064 | 34 | Novartis Pharmaceuticals Corporation ($301.84) |
| 2022 | $736.65 | 23 | Novartis Pharmaceuticals Corporation ($349.69) |
| 2021 | $270.99 | 15 | PFIZER INC. ($118.66) |
| 2020 | $333.81 | 19 | Novartis Pharmaceuticals Corporation ($67.90) |
| 2019 | $1,361 | 66 | Amgen Inc. ($239.00) |
| 2018 | $1,040 | 68 | Janssen Biotech, Inc. ($163.78) |
| 2017 | $1,053 | 61 | Novartis Pharmaceuticals Corporation ($107.30) |
All Payment Transactions
319 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/11/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: HORMONE THERAPY | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $17.67 | General |
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Genentech, Inc. | Phesgo (Biological), Tecentriq Hybreza | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: BioOncology | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 08/15/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Hematology | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.48 | General |
| 06/13/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: ONCOLOGY | ||||||
| 06/07/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Oncology | ||||||
| 05/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Rare Disease | ||||||
| 05/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 774 | 1,569 | $467,614 | $105,730 |
| 2022 | 10 | 744 | 1,653 | $372,237 | $111,033 |
| 2021 | 9 | 788 | 1,603 | $334,334 | $105,481 |
| 2020 | 26 | 1,835 | 37,013 | $2.3M | $559,033 |
Total Patients
4,141
Total Services
41,838
Medicare Billing
$881,276
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 360 | 1,015 | $310,038 | $69,708 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 212 | 303 | $65,592 | $12,694 | 19.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 90 | $38,767 | $9,228 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $19,950 | $4,552 | 22.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $15,840 | $3,798 | 24.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 38 | $6,384 | $2,289 | 35.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,137 | $1,453 | 28.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,147 | $1,289 | 31.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 19 | $1,759 | $720.67 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 315 | 1,001 | $237,237 | $69,782 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 335 | $54,940 | $15,765 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 57 | $18,183 | $6,292 | 34.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 41 | 41 | $18,614 | $5,631 | 30.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 87 | $13,746 | $4,649 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $12,565 | $3,415 | 27.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $7,531 | $2,553 | 33.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 25 | 48 | $4,128 | $1,358 | 32.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 16 | 17 | $3,808 | $1,207 | 31.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,485 | $380.90 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 311 | 888 | $197,079 | $61,741 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 242 | 388 | $58,267 | $18,128 | 31.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 52 | 72 | $21,688 | $7,432 | 34.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 39 | 39 | $17,066 | $5,309 | 31.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 51 | 51 | $17,534 | $5,050 | 28.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 35 | 89 | $13,412 | $4,633 | 34.5% |
About Dr. Randall Pierce, MD
Dr. Randall Pierce, MD is a Hematology & Oncology healthcare provider based in Carrollton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659378867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randall Pierce, MD has received a total of $6,978 in payments from pharmaceutical and medical device companies, with $1,119 received in 2024. These payments were reported across 319 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($5,292).
As a Medicare-enrolled provider, Pierce has provided services to 4,141 Medicare beneficiaries, totaling 41,838 services with total Medicare billing of $881,276. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Carrollton, GA
- Active Since 07/01/2005
- Last Updated 12/13/2017
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1659378867
Products in Payments
- KISQALI (Drug) $988.37
- ADCETRIS (Biological) $194.59
- TUKYSA (Drug) $181.62
- JAKAFI (Drug) $178.09
- IMBRUVICA (Drug) $174.78
- IBRANCE (Drug) $170.57
- KEYTRUDA (Biological) $169.06
- OPDIVO (Biological) $164.45
- Lenvima (Drug) $155.49
- Kyprolis (Biological) $149.44
- Imbruvica (Drug) $136.37
- DARZALEX (Biological) $129.63
- LYNPARZA (Drug) $128.37
- ZOLADEX (Drug) $99.18
- ERLEADA (Drug) $99.00
- Revlimid (Drug) $91.20
- Pomalyst (Drug) $86.96
- Lonsurf (Drug) $85.73
- TASIGNA (Drug) $83.47
- Neulasta (Biological) $81.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Carrollton
Dr. Vibha Thomas, M.d, M.D
Hematology & Oncology — Payments: $19,445
Hematology & Oncology $19,445
Dr. Yuesheng Qu, M.d, M.D
Hematology & Oncology — Payments: $8,797
Hematology & Oncology $8,797
Dr. Bradley Larson, Md, MD
Hematology & Oncology — Payments: $5,850
Hematology & Oncology $5,850
Dr. Enrique Perez, Md, MD
Hematology & Oncology — Payments: $5,579
Hematology & Oncology $5,579